This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Exelixis, Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Susana Nieto-Bergman: Innovator in the PTEN/AKT Pathway
Introduction
Susana Nieto-Bergman is a prominent inventor based in Berkeley, CA (US). She has made significant contributions to the field of biotechnology, particularly in understanding the PTEN/AKT signaling pathway. Her work has implications for therapeutic targets in various disorders.
Latest Patents
Susana holds a patent titled "EEF2K as modifiers of the PTEN/AKT pathway and methods of use." This patent identifies human EEF2K genes as modulators of the PTEN/AKT pathway, highlighting their potential as therapeutic targets for disorders associated with defective PTEN/AKT function. The patent also provides methods for identifying modulators of PTEN/AKT by screening for agents that can modulate the activity of EEF2K. She has 1 patent to her name.
Career Highlights
Susana is currently associated with Exelixis, Inc., where she continues her research and development efforts. Her work has been instrumental in advancing our understanding of critical biological pathways and their implications for health.
Collaborations
Some of her notable coworkers include Arthur Brace and Robert A Blake, who have collaborated with her on various projects.
Conclusion
Susana Nieto-Bergman is a key figure in the field of biotechnology, with her innovative work on the PTEN/AKT pathway paving the way for future therapeutic advancements. Her contributions are vital to the ongoing research in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile